Why is "Cachexia" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-03-11 06:13:43
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
This topic is not currently in the ranking.
Wikipedia Overview
Cachexia is a syndrome that occurs in people with certain illnesses, causing muscle loss that cannot be fully reversed with improved nutrition. It most commonly occurs in cases of cancer, congestive heart failure, chronic obstructive pulmonary disease, chronic kidney disease, and AIDS. These conditions change how the body handles inflammation, metabolism, and brain signaling. This can lead to muscle loss and other harmful changes to body composition over time. Unlike weight loss from inadequate caloric intake, cachexia mainly causes muscle loss and can happen with or without fat loss. Diagnosis of cachexia is difficult because there are no clear guidelines, and its occurrence varies from one affected person to the next.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
Not wanting to eat protein may be early herald of cancer cachexia - Medical Xpress
-
Lipid nanoparticles deliver dual therapy for lung cancer - Drug Target Review
-
Multi-omics profiling of cachexia-targeted tissues reveals a spatio-temporally coordinated response to cancer - Nature
-
Pursuing the Next Breakthrough in Cancer Cachexia - Pfizer
-
What is Cancer Cachexia? Ways to Take Action - Pancreatic Cancer Action Network
-
National Mortality Patterns of Cancer Cachexia in Gastrointestinal Malignancies in the United States: A Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research (CDC WONDER) Analysis (2018–2023) - Cureus
-
Malnutrition and Cachexia in Inpatients With Acute Cardiac Conditions - professional.heart.org
-
Cancer cachexia in STK11/LKB1 -mutated non-small cell lung cancer is dependent on tumor-secreted GDF15 - Nature
-
PanCAN PurpleStride Chicago Premier Sponsor Endevica Bio: Founded on the Mission to Find a Cure for Cachexia - Pancreatic Cancer Action Network
-
Targeting of HIF2-driven cachexia in kidney cancer - Nature
-
Cancer cachexia contender enters first pivotal trial - Nature
-
Mechanistic insights make cancer cachexia a targetable syndrome - Nature
-
Molecular subtypes of human skeletal muscle in cancer cachexia - Nature
-
Impaired cAMP–PKA–CREB1 signalling drives mitochondrial dysfunction in skeletal muscle during cancer cachexia - Nature
-
Clues to why the weight-loss condition cachexia arises when cancer occurs - Nature
-
Reframing cancer cachexia: the vagal brain–liver axis as a novel neuro-metabolic target - Nature
-
A skin patch could disrupt cancer’s muscle-wasting effect - Nature
-
Concurrent PIK3CA mutant promotes cachexia through inflammatory signaling in EGFR mutant lung cancer - Nature
-
Curanex Pharmaceuticals Highlights Patient Case Supporting Phyto-N's Potential in Cancer Cachexia Treatment - Quiver Quantitative
-
Developing a Path Forward in Cancer Cachexia - Pfizer
-
Spatio-temporal metabolic alterations in cachexia - Nature
-
Open-Label Ponsegromab Appears Effective in Cancer-Associated Cachexia - Oncology Nursing News
-
EXCLUSIVE: Penny Stock Curanex Expands Cachexia Focus Backed By Patient Recovery Narratives - Benzinga
-
Reawakening cAMP signalling in cancer cachexia - Nature
-
The role of PPARγ in cancer cachexia: friend or foe? - Frontiers
-
Five critically ill patient accounts inform Curanex's cachexia focus - Stock Titan
-
One cancer patient kept working 2+ years in Curanex Phyto-N case - Stock Titan
-
Malnutrition, cachexia and sarcopenia as susceptibility factors for cardiovascular complications in patients with cancer - Frontiers
-
Uncovering New Paths to Detect and Treat Cancer-Induced Cachexia - Johns Hopkins Medicine
-
EXCLUSIVE: Curanex Highlights Case Study Supporting Cachexia Focus In Oncology Strategy - Sahm
-
University of Houston Researchers Identify New Target to Counteract Muscle Wasting in Pancreatic Cancer - University of Houston
-
Breakthrough genetic research holds keys to fighting devastating muscle wasting in cancer - University of Alberta
-
Cancer cell study sheds light on cachexia's origins - Medical Xpress
-
Molecular Insights Into Cancer Cachexia: An Evolution in Identifying the Syndrome - CancerNetwork
-
Cancer Cachexia Market Outlook Report 2026-2030: Personalized Treatments and Digital Tools Elevate Cancer Cachexia Care; Total Revenue to Grow by $600 Million - Yahoo Finance
-
Skeletal muscle endothelial dysfunction through the activin A–PGC1α axis drives progression of cancer cachexia - Nature
-
Temporal Trends in Mortality Related to Pancreatic Cancer and Cachexia in the United States - Cureus
-
Vascular collapse leads to muscle wasting in cancer cachexia - Nature
-
Interim Phase 2 Data for Cancer Anorexia-Cachexia Treatment Show Promise - Targeted Oncology
-
Organs Synchronize Their Metabolic Response in Cancer Wasting Syndrome - the-scientist.com
-
Race-based differences in serum biomarkers for cancer-associated cachexia in a diverse cohort of patients with pancreatic ductal adenocarcinoma | Communications Medicine - Nature
-
Curanex Expands Its Drug Development Pipeline to Include Cancer Cachexia, Representing a Multi-Billion-Dollar Market Opportunity and Important Step In The Company’s Evolution Into a Broader Therapeutics Development Company - Yahoo Finance
-
Unraveling the role of STAT3 in Cancer Cachexia: pathogenic mechanisms and therapeutic opportunities - Frontiers
-
Artelo’s cancer cachexia drug succeeds in Phase II - Clinical Trials Arena
-
CatalYm joins Pfizer in pivotal cachexia push | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline
-
The Power of Collaboration – Novel Model System to Study Lung Cancer Cachexia | UVM Cancer Center - University of Vermont
-
World Cancer Cachexia Awareness Day 2025: Giving Voice to an Overlooked Challenge - Oncodaily
-
How Can Cancer Cachexia Be Treated? Molecular Subtypes May Be Key - CancerNetwork
-
Anirban Maitra: How Tumors Hijack Immune-Neural Circuits to Drive Cancer Cachexia - Oncodaily
-
High expression of the cachexia-related protein Fn14 in esophageal squamous cell carcinoma correlates with poor chemotherapy response and anti-Fn14 therapy decreases chemotherapeutic resistance | British Journal of Cancer - Nature
-
Sex-specific survival but not tissue wasting in the KPP mouse model of pancreatic cancer-induced cachexia - American Physiological Society Journal
-
Muscle RNome Analysis Reveals 2 Molecular Subtypes Associated With Cancer Cachexia - CancerNetwork
-
Muscle-Wasting Syndrome Cachexia Tied to Liver REV-ERBα Disruption - Inside Precision Medicine
-
Human organoid mimics cancer-induced cachexia - BioWorld News
-
Research by Deena Snoke, Ph.D., Seeks Treatment for Lung Cancer Cachexia - University of Vermont
-
Liver identified as key driver of cancer cachexia - News-Medical
-
Malnutrition Poorly Affects Survival With CCRT in Advanced Cervical Cancer - CancerNetwork
-
Weight loss in cancer: Organs respond to the disease in a coordinated way, study finds - Medical Xpress
-
The complex heterogeneity of immune cell signatures across wasting tissues with C26 and 5-fluorouracil-induced cachexia - American Physiological Society Journal
-
No U.S.-approved treatment exists for cancer cachexia. Curanex adds it - Stock Titan
-
Cachexia Worsens Prognosis in Older Patients With Advanced SCLC - AJMC
-
Curanex (Nasdaq: CURX) targets cancer cachexia in expanded pipeline - Stock Titan
-
Artelo’s cancer cachexia drug succeeds in Phase II - MSN
-
Pancreatic Cancer-Derived Extracellular Vesicles Enriched with miR-223-5p Promote Skeletal Muscle Wasting Associated with Cachexia - Wiley
-
Vagus nerve modulation can effectively halt the progression of cancer-associated cachexia - News-Medical
-
Cachexia Care at MASCC 2025: Hormonal Strategies Explored - Oncodaily
-
Cancer Cachexia Clinical Trial Pipeline Shows Potential - GlobeNewswire
-
ESMO: Pfizer sees year-long weight gain in cancer patients with wasting condition - Fierce Biotech
-
Inflammation in cancer cachexia: still the central tenet or just another player? - American Physiological Society Journal
-
Meeting report: the inaugural muscle biology and cachexia conference at the University of Houston, May 18-20, 2025, Houston, Texas, USA - Frontiers
-
R1 Larner Spotlight: Research by Deena Snoke, Ph.D., Seeks Treatment for Lung Cancer Cachexia - University of Vermont
-
Curanex adds cancer cachexia to drug development pipeline - Investing.com
-
Amy C. Moore: Marking the First-Ever Cancer Cachexia Awareness Day at ILCSC25 - Oncodaily
-
Anirban Maitra: New Insights on HIF2-Driven Cachexia - Oncodaily
-
Curanex Highlights Five Additional Patient Cases Further Supporting the Potential of Its Lead Candidate in Cancer Cachexia, Advanced Cancer Supportive Care and Severe Systemic Decline - The Manila Times
-
Jean-Charles Soria: Cancer Cachexia – A Lethal, Underdiagnosed Syndrome - Oncodaily
-
Researchers Develop Dual Treatment for Lung Cancer and Muscle Loss - National Today
-
Hepatic gluconeogenesis and PDK3 upregulation drive cancer cachexia in flies and mice - Nature
-
Treating Cancer Cachexia: Progress Looks Possible - National Cancer Institute (.gov)
-
A nanoparticle therapy to treat lung cancer and associated muscle wasting at the same time - Phys.org
-
Curanex adds cancer cachexia to drug development pipeline By Investing.com - Investing.com South Africa
-
FibroBiologics Announces Issuance of Canadian Patent Covering Novel Fibroblast-Based Treatment for Cachexia - Yahoo Finance
-
Targeting brain-liver pathway with electronic wearables could prevent cancer-associated weight and muscle loss - UT MD Anderson
-
Curanex Adds Cancer Cachexia to Core Drug Pipeline - TipRanks
-
Cancer Cachexia Market to Grow at 4.8% CAGR Through 2032 - Market.us
-
Ponsegromab Potentially Effective Against Cachexia - National Cancer Institute (.gov)
-
AACR 2025: AI-Driven Model For Identifying Cancer Cachexia - The ASCO Post
-
Poorly functioning blood vessels lead to muscle wasting in cancer - UIC today
-
Epigenetic information could harbour biomarkers of diagnosis and prognosis - ESMO Daily Reporter
-
Cancer-associated cachexia — understanding the tumour macroenvironment and microenvironment to improve management - Nature
-
Actimed grants Mankind rights to cachexia products in Indian subcontinent - The Pharma Letter
-
Ponsegromab for the Treatment of Cancer Cachexia - NEJM
-
Ponsegromab Crashes Out in Frailer Heart Failure Patients - MedPage Today
-
Curanex Expands Its Drug Development Pipeline to Include Cancer Cachexia, Representing a Multi-Billion-Dollar Market Opportunity and Important Step In The Company's Evolution Into a Broader Therapeutics Development Company - 富途牛牛
-
Ghrelin peptide in heart failure: when is showtime? - Frontiers
-
Curanex adds cancer cachexia to drug development pipeline By Investing.com - Investing.com Canada
-
Terasaki Institute researchers reveal vagus nerve modulation as key to combating cancer-associated cachexia featured in cell - EurekAlert!
-
Limiting serine availability during tumor progression promotes muscle wasting in cancer cachexia - Nature
-
Oxytocin treatment counteracts severe cancer-induced muscle loss - Sapienza Università di Roma
-
A neuroimmune circuit mediates cancer cachexia-associated apathy - Science | AAAS
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.